Angene Chemical
Draw
|
Currency :
Home Products

AG00IMK8

90098-04-7 | 2-​(4-​Chloro-​benzoylamino)​-​3-​(2-​hydroxy-​quinolin-​4-​yl)​-​propionic acid

Chemical structure of 2-​(4-​Chloro-​benzoylamino)​-​3-​(2-​hydroxy-​quinolin-​4-​yl)​-​propionic acid, CAS 90098-04-7
AG00IMK8
sdsSDS
sdsCOA

Price

$0.00

Add to Cart
WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 90098-04-7
Catalog Number AG00IMK8(AGN-PC-0BSKEC)
Chemical Name 2-​(4-​Chloro-​benzoylamino)​-​3-​(2-​hydroxy-​quinolin-​4-​yl)​-​propionic acid
IUPAC Name 2-[(4-chlorobenzoyl)amino]-3-(2-oxo-1H-quinolin-4-yl)propanoic acid
InChI InChI=1S/C19H15ClN2O4/c20-13-7-5-11(6-8-13)18(24)22-16(19(25)26)9-12-10-17(23)21-15-4-2-1-3-14(12)15/h1-8,10,16H,9H2,(H,21,23)(H,22,24)(H,25,26)
InChI Key ALLWOAVDORUJLA-UHFFFAOYSA-N
MDL Number MFCD11114396
Molecular Formula C19H15ClN2O4
Molecular Weight 370.7864
NSC Number 758955
SMILES O=C(O)C(NC(C1=CC=C(Cl)C=C1)=O)CC2=CC(NC3=C2C=CC=C3)=O
Synonyms
2-(4-chlorobenzoylamino)-3-(2(1H)-quinolinon-4-yl)propionic acid, OPC 12759, OPC-12759, rebamipide, rebamipide, (+)-isomer, rebamipide, (-)-isomer, rebamipide, 90098-04-7, Proamipide, Mucosta, 111911-87-6, OPC-12759, Pramipide, Rebamipide [INN:JAN], Rebamipidum [INN-Latin], OPC 12759, CCRIS 3585, Rebamipide hydrate, 2-(4-Chlorobenzoylamino)-3-(1,2-dihydro-2-oxo-4-quinolyl)propionic acid, 2-[(4-chlorobenzoyl)amino]-3-(2-oxo-1H-quinolin-4-yl)propanoic acid, Mucosta hydrate, 139344-42-6, NCGC00095161-01, Proamipide hydrate, 2-(4-Chlorobenzamido)-3-[2(1H)-quinolinon-4-yl]propionic Acid, 2-(4-chlorobenzamido)-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid, (+-)-2-(4-Chlorobenzoylamino)-3-(2(1H)-quinolinon-4-yl)propionic acid, (+-)-1,2-Dihydro-alpha-((4-chlorobenzoyl)amino)-2-oxo-4-quinolinepropanoic acid, DSSTox_CID_25937, DSSTox_RID_81235, DSSTox_GSID_45937, OPC 12759 hydrate, Rebamipidum, 2-(4-chlorobenzoylamino)-3-(2(1H)-quinolinon-4-yl)propionic acid, 2-[[(4-chlorophenyl)-oxomethyl]amino]-3-(2-oxo-1H-quinolin-4-yl)propanoic acid, 4-Quinolinepropanoic acid, 1,2-dihydro-alpha-((4-chlorobenzoyl)amino)-2-oxo-, (+-)-, CAS-90098-04-7, SR-05000001520, C19H15ClN2O4, Rebamipida [INN-Spanish], 2-(4-chlorobenzoylamino)-3-[2(1H)-quinolinon-4-yl]propionic acid, N-[(4-chlorophenyl)carbonyl]-3-(2-oxo-1,2-dihydroquinolin-4-yl)alanine, 2-[(4-chlorophenyl)carbonylamino]-3-(2-oxidanylidene-1H-quinolin-4-yl)propanoic acid, Mucosta (TN), AC1L1JHF, Spectrum2_000039, Spectrum3_001959, Rebamipide (JP17/INN), BSPBio_003559, GTPL871, MLS006011883, SCHEMBL221527, SPECTRUM1505310, SPBio_000137, QUI103, rebamipide 111911-87-6, CHEMBL1697771, DTXSID8045937, CHEBI:93814, CTK8B3342, KBio3_002880, KS-00000SHL, AOB5606, OPC-759, ALLWOAVDORUJLA-UHFFFAOYSA-N, HMS1922B20, HMS2090L13, HMS3655L11, HMS3714A15, Pharmakon1600-01505310, BCP07230, HY-B0360, OPC12759, Tox21_111460, ANW-42341, BBL011328, CCG-39619, CR0013, MFCD00866895, MFCD11114396, NSC758955, s2032, STK577121, STL146407, (+-)-alpha-(p-Chlorobenzamido)-1,2-dihydro-2-oxo-4-quinolinepropionic acid, AKOS005501649, AKOS005721106, Tox21_111460_1, 111911-87-6 (anhyd.), AC-6841, AC-7588, AN-9620, CS-2416, DB11656, MCULE-3675104222, NSC-758955, (+-)-alpha-((4-Chlorobenzoyl)amino)-1,2-dihydro-2-oxo-4-quinolinepropanic acid, 2-(4-chloro-benzoylamino)-3-(2-oxo-1,2-dihydro-quinolin-4-yl)-propionic acid, 4-Quinolinepropanic acid, alpha-((4-chlorobenzoyl)amino)-1,2-dihydro-2-oxo-, (+-)-, NCGC00095161-02, NCGC00095161-03, NCGC00095161-04, NCGC00095161-05, AK316145, AN-35058, SC-15936, SMR003309276, SBI-0207054.P001, AB0073108, AB1009629, LS-142127, LS-142128, FT-0630971, FT-0655225, R0085, SW199113-2, D01121, AB01275518-01, AB01275518_02, AB01275518_03, 911R876, A802443, A843443, I14-0511, Q-201660, SR-05000001520-1, SR-05000001520-2, SR-05000001520-3, BRD-A15909516-001-02-5, BRD-A15909516-001-03-3, 2-(4-chlorobenzoylamino)-3-(2-quinolon-4-yl)propionic acid, 2-(4-chlorobenzoylamino)-3-[2(1h)-quinolinon-4-yl] propionic acid, N-[(4-chlorophenyl)carbonyl]-3-(2-hydroxyquinolin-4-yl)alanine, 2-(4-chlorobenzoylamino)-3-(2-oxo-1,2-dihydroquinolin-4-yl)propionic acid, 4-Quinolinepropanoic acid, |A-[(4-chlorobenzoyl)amino]-1,2-dihydro-2-oxo-, 4-Quinolinepropanoicacid,a-[(4-chlorobenzoyl)amino]-1,2-dihydro-2-oxo-, (+/-)-2-(4-CHLOROBENZOYLAMINO)-3-(2(1H)-QUINOLINON-4-YL)-PROPIONIC ACID, 4-Quinolinepropanoic acid, 1,2-dihydro-alpha-((4-chlorobenzoyl)amino)-2-oxo-,(+-)-, alpha-[(4-Chlorobenzoyl)amino]-1,2-dihydro-2-oxo-4-quinolinepropanoic acid hydrate, null, Rebamipida, rebamipide, (+)-isomer, rebamipide, (-)-isomer, UNII-LR583V32ZR, D03BQP, LR583V32ZR, CID5042, C19-H15-Cl-N2-O4, CS-O-30754, C052785, |A-[(4-Chlorobenzoyl)-amino]-1,2-dihydro-2-oxo-4-quinolinepropanoic Acid, alpha-[(4-Chlorobenzoyl)amino]-1,2-dihydro-2-oxo-4-quinolinepropanoic acid, Rebamipide, 99%, Inducer of endogenous prostaglandin and a oxygen-derived free radical scavenger - 25MG 25mg,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited